Biocon
India Will Be Bright Shining Light For World: OYO Founder Ritesh Agarwal
Banking - Published date: .
India will be the bright shining light for the world driven by its young people who are "driving startups", hospitality ... Read more
Biocon Shares Trim Most Of Early Gains, End Flat Amid Profit-taking
Banking - Published date: .
Shares of Biocon trimmed most of their early gains and ended flat on Wednesday amid profit-taking. During the early tra... Read more
Serum Institute Of India Doubles Biocon Investment To $300 Million
Banking - Published date: .
The earlier investment by SILS in BBL was at a valuation of $4.9 billion, and the fresh $150-million investment pushes i... Read more
Serum Institute To Pump In Additional $150 Mn In Biocon Biologics
Banking - Published date: .
Serum Institute of Life Sciences will invest an additional USD 150 million in Biocon Biologics as the partners decided t... Read more
Biocon Sells 9.96% Stake In Contract Research Firm Syngene Via Open Market
Banking - Published date: .
Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing Read more
Biocon Sells 5.4% Stake In Arm Syngene International For Rs 1,220 Cr
Banking - Published date: .
Drugmaker Biocon on Tuesday divested a 5.4 per cent stake in its research arm Syngene International for a little over Rs... Read more
SEC Recommendation In Accordance With Guidelines: Biocon Biologics
Banking - Published date: .
The company said its product approvals are backed by science and clinical data Read more
Biocon Likely To Seek Full Marketing Authorisation For Covid-19 Drug
Banking - Published date: .
Expects results from phase 4 study of itolizumab by end of this quarter Read more
Top Headlines: Parliament Meets, Firms Face Heat On Independent Valuation
Banking - Published date: .
Here are the top headlines on Monday morning Read more
Market Reacts Negatively To Biocon's Weaker Results, Exit Of Biologics' MD
Banking - Published date: .
Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professiona... Read more
USFDA Informs Biocon, Mylan Of Deferred Action On Biosimilar License Plea
Banking - Published date: .
Biocon said its arm, Biocon Biologics, and Mylan have been informed by the USFDA of a deferred action on the biologics l... Read more
Biocon Biologics Gets Capital Injection Of Rs $150 Mn From Goldman Sachs
Banking - Published date: .
Transaction values the IPO-bound biologics arm of Biocon at $3.94 billion Read more
Biocon Gets A Shot In The Arm With FDA Approval For Insulin Glargine
Banking - Published date: .
The drug will be major contributor in the firm's bid to reach $1 billion revenue target by FY22, says biologics CEO Hama... Read more
Biocon MD Kiran Mazumdar-Shaw Named EY World Entrepreneur Of The Year
Banking - Published date: .
The Biocon MD was picked from among 46 nominations from 41 countries Read more
Will Invest Rs 2,000 Cr In Small Molecules Segment In 3-4 Years: Biocon MD
Banking - Published date: .
In a Q&A, Biocon CEO and MD Siddharth Mittal explains why he believes his company is on track to achieve the $1 bill... Read more
Biocon's US Prospects Get A Boost After Company Receives EIR From USFDA
Banking - Published date: .
The insulin patent win, clearance of Malaysian unit and oncology biosimilar filing are triggers Read more
Biocon Receives EIR From USFDA For Good Manufacturing Practice Inspection
Banking - Published date: .